Atlanta Endocrine Associates

All patients with type 2 diabetes should be screened for NAFLD/MASLD. https://www.medscape.com/viewarticle/993715

Our paper on the identification of high-risk patients with NAFLD/MASLD in endocrinology clinics. Free download via this author link.
https://authors.elsevier.com/c/1hrTF_,3UnYHv6r

Dr. Isaacs was interviewed for this story for CBS Evening News about

Eli Lilly seeks FDA approval for weight loss drug tirzepatide Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be s...

Diabetes medications that promote weight loss improve NAFLD. But, it remains unclear if glycemic control itself is beneficial for NAFLD.
https://www.healio.com/news/endocrinology/20230118/meeting-target-hba1c-may-improve-nafld-for-adults-with-type-2-diabetes

Reproductive aged women have lower rates of NAFLD compared with men; however, NAFLD prevalence in postmenopausal women is similar to or exceeds that in men. https://www.healio.com/news/womens-health-ob-gyn/20230109/odds-of-nonalcoholic-fatty-liver-disease-greater-after-menopause

The ability of and to melt weight away by tweaking biology gives credence to the idea that obesity is a disease. https://www.nature.com/articles/d41586-022-04505-7

Weight regain is expected if a weight loss medication is discontinued. My comments about Remi Bader's use and discontinuation of for Insider.

Model Remi Bader says she tried weight-loss drug semaglutide, but gained all her weight back when she quit An endocrinologist told Insider that semaglutide is meant for long-term use because it treats chronic conditions like obesity and diabetes.

Recommendations to enable and optimize a multidisciplinary approach in NAFLD care.

Thread by @scottisaacsmd on Thread Reader App : Recommendations to enable and optimize a multidisciplinary approach in care. nature.com/articles/s4385… Evaluate benefit and cost-effective...…

It was such an honor to be part of the first annual Canadian NAFLD & NASH Summit. Here is a recording of my presentation about the relationship between NAFLD/NASH and Type 2 Diabetes, obesity, cardiovascular risk.

Video 9: Dr. Scott Isaacs NAFLD/NASH and the relationship to Type-2 Diabetes, Obesity & Cardiovascular Risk with Dr. Scott Isaacs, Endocrinologist.

Dr. Isaacs' new article on testing for fatty liver disease.

A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis A practical use of non-invasive tests in clinical practice to identify and stratify high-risk patients with non-alcoholic steatohepatitis.

Twittorial about the link between fatty liver and heart disease. https://threadreaderapp.com/thread/1601962266315874311.html

Reversing fatty liver disease is a key factor in diabetes remission.

Nonalcoholic Fatty Liver Disease Endocrinology and Metabolism Clinics of North AmericaAvailable online 18 November 2022In Press, Corrected ProofWhat are Corrected Proof articles?Nonalcoholic Fatty Liver DiseaseAuthor links open overlay panelScottIsaacsMDabShow moreShareCitehttps://doi.org/10.1016/j.ecl.2022.06.007Get rights and con...